Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CFO Fawwad Qureshi sold 640 shares of Trupanion stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $43.12, for a total transaction of $27,596.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Trupanion Price Performance
NASDAQ:TRUP traded up $0.81 during trading hours on Monday, hitting $43.33. 390,949 shares of the stock traded hands, compared to its average volume of 715,155. The company has a quick ratio of 1.62, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. Trupanion, Inc. has a 1 year low of $19.14 and a 1 year high of $44.10. The company has a market cap of $1.83 billion, a price-to-earnings ratio of -67.73 and a beta of 1.77. The stock has a 50 day moving average price of $32.22 and a 200 day moving average price of $28.68.
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.04. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The business had revenue of $314.80 million for the quarter, compared to the consensus estimate of $309.33 million. During the same quarter in the previous year, the firm earned ($0.33) earnings per share. The company’s revenue for the quarter was up 16.3% on a year-over-year basis. Sell-side analysts forecast that Trupanion, Inc. will post -0.41 EPS for the current fiscal year.
Hedge Funds Weigh In On Trupanion
Analysts Set New Price Targets
A number of brokerages have recently commented on TRUP. Piper Sandler lifted their price target on shares of Trupanion from $30.00 to $38.00 and gave the stock a “neutral” rating in a research note on Friday, August 9th. Bank of America upgraded shares of Trupanion from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $35.00 to $49.00 in a research note on Thursday, May 16th. Canaccord Genuity Group dropped their price objective on shares of Trupanion from $40.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, May 3rd. William Blair assumed coverage on shares of Trupanion in a report on Friday, July 19th. They issued an “outperform” rating on the stock. Finally, Northland Securities raised their price objective on shares of Trupanion from $30.00 to $35.00 and gave the stock a “market perform” rating in a report on Friday, August 9th. Four equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $36.17.
Check Out Our Latest Analysis on Trupanion
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- Overbought Stocks Explained: Should You Trade Them?
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- How to Find Undervalued Stocks
- 2 Option Strategies to Maximize Profits in a Bear Market
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.